Strategic Alliances, Joint Ventures and Licensing Transactions TRANSACTIONAL

WilmerHale's Strategic Alliances, Joint Ventures and Licensing Transactions lawyers leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovate and effective technology-related agreements.


In the highly competitive worlds of biotechnology and information technology, licensing transactions and strategic alliances can make the difference between success and failure. The attorneys in WilmerHale's Technology Transactions and Licensing Practice—many of whom have backgrounds in computer engineering, biochemistry, and other technical fields—collaborate closely with our corporate, licensing, intellectual property and tax lawyers to negotiate agreements for clients across a broad spectrum of industries. They handle hundreds of complex joint ventures, strategic alliances, and outsourcing and licensing transactions each year, some of which span international borders. Their work often receives industry commendation for its significance in shaping the future of science and technology.

Contacts

Sort By
Barrett, Steven D.

Steven D. Barrett

Co-Chair, Technology Transactions and Licensing Practice Group

+1 617 526 6238 (t)

steven.barrett@wilmerhale.com

Juran, Belinda M.

Belinda M. Juran

Co-Chair, Technology Transactions and Licensing Practice Group

Co-Chair, Life Sciences Group

+1 617 526 6987 (t)

belinda.juran@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Coates, Sam

Samuel S. Coates

Partner

+1 650 858 6000 (t)

samuel.coates@wilmerhale.com

Experience

We represent many market leaders in technology and life sciences, including: 

  • Cutting-edge biotech developers Epizyme, Macrogenics, Merrimack, Ophthotech and Vedanta
  • Gene-therapy innovator Spark Therapeutics
  • Consumer electronics companies Bose and TiVo
  • Telecommunications leaders Broadcom and Altiostar
  • Data analysis pioneers Kensho and Thasos 
  • Software and IT developers Toyota InfoTechnology Center and Progress
  • Pharmaceutical company Bristol-Myers Squibb
  • Healthcare IT innovator Caradigm

Read more about the transactions we've done.

Life Sciences

Helping clients protect their innovations, forge strategic partnerships and successfully navigate a complex, dynamic industry.

For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale's experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their business possible. Our attorneys excel at brokering material transfer agreements, manufacturing and supply agreements, confidentiality agreements and distribution agreements. They also frequently represent biotech venture capital clients as they license patents—the foundations of their companies—from leading universities across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm's patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters.

Hardware, Software, IT and Services

We assist with hundreds of agreements each year, guiding clients in nearly every technological field through the transactions that allow them to lead and innovate.

Our clients in the ever-changing and fiercely competitive hardware, software, IT and services depend on us to strategize and negotiate transactions that take advantage of opportunities now while protecting their innovations and shoring up strong industry relationships for the future. We structure, negotiate and draft all types of licensing, distribution, product development, joint venture and strategic alliance agreements for these clients, often drawing on the deep experience of WilmerHale's regulatory, intellectual property, business and tax lawyers. Our attorneys keep a close watch on Internet-related legislative and regulatory developments in the United States, the European Union and elsewhere, and leverage our up-to-the-minute knowledge to advise clients in areas such as data privacy and security, copyright infringement, and export restrictions.

Recognition

  • Best Lawyers in America – Recognized nearly 100 WilmerHale partners in 2015, naming nine "Lawyer of the Year," including David Westenberg as Boston Information Technology Law Lawyer of the Year. From 2010-2013, WilmerHale's Technology Law practice received a number one ranking.
  • BioPharm Insight – Consistently lists our attorneys among the leading legal advisors for biotech and pharma licensing agreements in the global, North American and European and Asia-Pacific ranking tables. 
  • Chambers Global – Named WilmerHale among the best in the United States in outsourcing in 2014 and 2015.
  • Chambers USA: America's Leading Lawyers for Business – Named the firm in 2014 and 2015 among the best in the nation in technology and outsourcing, and recognized the "enormously respected" Robert Finkel as a "thought leader in the sourcing industry" with "unparalleled" industry knowledge in 2012-2014.
  • LMG Life Sciences – Ranked the firm in its 2013 and 2014 editions in the areas of patent prosecution, corporate, and licensing and collaboration. The firm was also named a 2014 "Lifecycle Firm," meaning the firm is regarded as one of the best full-service law firms serving the life sciences industry. Co-Chair Steven Barrett also has been named a "Life Sciences Star" in the 2012-2014 editions.
  • Super Lawyers – Named Co-Chair Steven Barrett a "Massachusetts Super Lawyer" in the 2014 edition of Boston Magazine.
  • The Legal 500 United States – Recognized Co-Chair Belinda Juran in 2013 as "a fantastic collaborator" and "outstanding in licensing."
  • U.S. News - Best Lawyers® – In the 2014 "Best Law Firms" rankings, our technology law practice was ranked in the first-tier nationally and in Boston. Our information technology law practice was also ranked in the third-tier nationally and second-tier in Boston.
  • Who's Who Legal – Recognized Co-Chair Steven Barrett as a leader in life sciences in the 2015 edition.

Publications & News

View

May 6, 2015

Selected 2015 Strategic Alliances, Joint Venture and Licensing Transactions

Our corporate, licensing, intellectual property and regulatory lawyers regularly handle a high volume of strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

May 6, 2015

Selected 2015 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

March 27, 2015

2015 Corporate Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

August 28, 2014

LMG Life Sciences Honors Firm, Attorneys with Top Rankings for Third Consecutive Year

The 2014 edition of LMG Life Sciences has been released, and it includes the recognition of nine WilmerHale practice areas and 17 attorneys.

May 14, 2014

WilmerHale Named Among America’s Top Corporate Law Firms

WilmerHale has been named to NYSE Governance Services and FTI Consulting’s “America’s Top Corporate Law Firms,” a comprehensive ranking of the top 25 firms in the nation.

May 6, 2014

2014 Corporate Reports

WilmerHale’s annual IPO, Venture Capital and M&A Reports provide comprehensive statistics and analysis that are hard to find elsewhere.

April 25, 2014

Selected 2014 Strategic Alliances, Joint Venture and Licensing Transactions

Our corporate, licensing, intellectual property and regulatory lawyers have recently handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

April 25, 2014

Selected 2014 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

November 1, 2013

WilmerHale Among U.S. News – Best Lawyers® “Best Law Firms” and Again Named International Arbitration “Law Firm of the Year”

The 2014 edition of the U.S. News – Best Lawyers® “Best Law Firms” list names WilmerHale as “Law Firm of the Year” in International Arbitration—this is the second consecutive year that the firm has won this honor—and honors WilmerHale as a first-tier law firm in 27 national and 60 metro-area rankings.

April 17, 2013

Selected 2013 Strategic Alliances, Joint Venture and Licensing Transactions

In 2013, our corporate, licensing, intellectual property and regulatory lawyers handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.